• 1. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182
• 2. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 3. Emerging investigator series: first-principles and thermodynamics comparison of compositionally-tuned delafossites: cation release from the (001) surface of complex metal oxides?
  Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651
• 4. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 5. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445

Research Briefing on Benzoic acid, 2-[(2-methylphenyl)thio]- (CAS: 87548-96-7) in Chemical Biology and Pharmaceutical Applications

Benzoic acid, 2-[(2-methylphenyl)thio]-, with the CAS number 87548-96-7, is a sulfur-containing benzoic acid derivative that has garnered significant attention in the field of chemical biology and pharmaceutical research. This compound, characterized by its unique thioether linkage and aromatic substitution pattern, has been explored for its potential applications in drug discovery and development. Recent studies have focused on its synthesis, biological activities, and potential therapeutic applications, making it a compound of interest for researchers in medicinal chemistry and pharmacology.

The synthesis of Benzoic acid, 2-[(2-methylphenyl)thio]- has been optimized in recent years, with several studies reporting efficient and scalable methods. A 2023 study published in the Journal of Medicinal Chemistry described a novel one-pot synthesis approach that significantly improved the yield and purity of the compound. This method involves the reaction of 2-methylbenzenethiol with 2-bromobenzoic acid under palladium catalysis, achieving yields of over 85%. The availability of high-purity material has facilitated more detailed investigations into its biological properties and potential applications.

In terms of biological activity, recent research has highlighted the compound's potential as a modulator of various cellular pathways. A 2024 study in Bioorganic & Medicinal Chemistry Letters reported that Benzoic acid, 2-[(2-methylphenyl)thio]- exhibits significant inhibitory activity against certain inflammatory enzymes, particularly cyclooxygenase-2 (COX-2), with an IC50 value of 3.2 μM. This suggests potential applications in the development of anti-inflammatory agents. Additionally, preliminary studies have indicated that the compound may interact with specific nuclear receptors, opening possibilities for its use in hormone-related therapies.

The pharmaceutical potential of Benzoic acid, 2-[(2-methylphenyl)thio]- has been further explored in drug formulation studies. Recent investigations have focused on its physicochemical properties, including solubility, stability, and partition coefficients. A 2023 publication in Pharmaceutical Research demonstrated that the compound shows favorable pharmacokinetic properties, with good oral bioavailability in animal models. These findings support its potential as a lead compound for further drug development efforts.

Looking forward, researchers are particularly interested in exploring the structure-activity relationships of Benzoic acid, 2-[(2-methylphenyl)thio]- derivatives. Several analogs have been synthesized and evaluated, with modifications primarily focused on the thioether linkage and aromatic rings. Early results suggest that specific substitutions can significantly enhance both potency and selectivity, providing a promising avenue for the development of novel therapeutic agents. The compound's unique chemical structure continues to make it a valuable scaffold in medicinal chemistry research.

In conclusion, Benzoic acid, 2-[(2-methylphenyl)thio]- (CAS: 87548-96-7) represents an important compound in contemporary chemical biology and pharmaceutical research. Its diverse biological activities, coupled with favorable physicochemical properties, make it a promising candidate for further investigation. As research progresses, this compound may contribute to the development of new therapeutic agents targeting inflammation, hormonal disorders, and potentially other disease areas. The continued exploration of its chemical space and biological effects will undoubtedly yield valuable insights for the field.

• 1527-12-4(2-(Phenylthio)benzoic acid)
• 3724-10-5(2-(Methylthio)benzoic acid)
• 21101-79-1(2-(ethylsulfanyl)benzoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)